Another Compounder’s Sterility Issues Result in Form 483

Drug Industry Daily
A A
A Montana compounder was hit with a 17-observation Form 483 due to issues with its sterile processing, contamination controls and other GMPs.

To View This Article:

Login

Subscribe To Drug Industry Daily